Comparison

WT1 37-45 (HLA-A*02:01) European Partner

Item no. EP11469_5
Manufacturer peptides & elephants
Amount 5 mg
Quantity options 1 mg 5 mg
Category
Type Peptides
Specific against Human (Homo sapiens)
Purity 0,95
Sequence VLDFAPPGA
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias VLDFAPPGA Wilms-Tumor-Protein HLA-A*02:01 Cancer
Available
Manufacturer - Category
Peptides
Shipping Temperature
freeze dried
Storage Conditions
Store dry at -20°C
C-Terminus
OH
N-Terminus
H
Counter-Ion
TFA
Description
Wilms tumor protein is a protein that is encoded by the WT1 gene on chromosome 11p in humans. WT1 is a tumour suppressor gene associated with the development of Wilms' Tumour, from which it was named. Mutations in exon 7 and 9 of WT1 have been recurrently identified in acute myeloid leukemia and associated with poorer prognosis and chemotherapy resistance. The WT1 peptide is a transcription factor that contains four zinc finger motifs at the C-terminus and a proline / glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system. WT1 has been ranked by the National Cancer Institute (NCI) as the Number 1 target for cancer immunotherapy.
Gene
WT1
Indication
Cancer
Protein
Wilms-Tumor-Protein
Allele
HLA-A*02:01
Remarks
sterile and endotoxin free

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close